Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (otvorí nové okno)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Zdroj‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Označenie‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (otvorí nové okno)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (otvorí nové okno)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Zdroj‎: Lancet 2018;391(10116):125-32.

Označenie‎: PubMed 29126600

Identifikátor digitálneho objektu‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (otvorí nové okno)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (otvorí nové okno)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Zdroj‎: Am J Perinatol 2013;30(5):407-13.

Označenie‎: PubMed 23023559

Identifikátor digitálneho objektu‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (otvorí nové okno)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (otvorí nové okno)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Zdroj‎: Am J Perinatol 2011;28(3):233-40.

Označenie‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (otvorí nové okno)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (otvorí nové okno)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Zdroj‎: Lancet 2017;389(10084):2105-16.

Označenie‎: PubMed 28456509

Identifikátor digitálneho objektu‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (otvorí nové okno)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (otvorí nové okno)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Zdroj‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Označenie‎: PubMed 26698831

Identifikátor digitálneho objektu‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (otvorí nové okno)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (otvorí nové okno)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Zdroj‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Označenie‎: PubMed 26952346

Identifikátor digitálneho objektu‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (otvorí nové okno)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (otvorí nové okno)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Zdroj‎: Obstet Gynecol 2007;110(6):1270-8.

Označenie‎: PubMed 18055720

Identifikátor digitálneho objektu‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (otvorí nové okno)

The use of recombinant activated FVII in postpartum hemorrhage. (otvorí nové okno)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Zdroj‎: Clin Obstet Gynecol 2010;53(1):219-27.

Označenie‎: PubMed 20142658

Identifikátor digitálneho objektu‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (otvorí nové okno)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (otvorí nové okno)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Zdroj‎: J Perinat Med 2011;40(1):43-9.

Označenie‎: PubMed 22017328

Identifikátor digitálneho objektu‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (otvorí nové okno)

Postpartum hemorrhage: when uterotonics and sutures fail. (otvorí nové okno)

James AH, McLintock C, Lockhart E.

Zdroj‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Označenie‎: PubMed 22430921

Identifikátor digitálneho objektu‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (otvorí nové okno)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (otvorí nové okno)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Zdroj‎: Int J Hematol 2012;95(1):57-63.

Označenie‎: PubMed 22160834

Identifikátor digitálneho objektu‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (otvorí nové okno)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (otvorí nové okno)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Zdroj‎: J Thromb Haemost 2015;13(4):520-9.

Označenie‎: PubMed 25594352

Identifikátor digitálneho objektu‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (otvorí nové okno)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (otvorí nové okno)

Lim Y, Loo CC, Chia V, Fun W.

Zdroj‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Označenie‎: PubMed 15491576

Identifikátor digitálneho objektu‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (otvorí nové okno)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (otvorí nové okno)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Zdroj‎: Br J Haematol 2001;114(1):174-6.

Označenie‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (otvorí nové okno)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (otvorí nové okno)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Zdroj‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Označenie‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (otvorí nové okno)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (otvorí nové okno)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Zdroj‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Označenie‎: PubMed 22489992

Identifikátor digitálneho objektu‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (otvorí nové okno)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (otvorí nové okno)

Pepas LP, Arif-Adib M, Kadir RA.

Zdroj‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Označenie‎: PubMed 17018493

Identifikátor digitálneho objektu‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (otvorí nové okno)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (otvorí nové okno)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Zdroj‎: Anesth Analg 2009;109(6):1908-15.

Označenie‎: PubMed 19923520

Identifikátor digitálneho objektu‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (otvorí nové okno)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (otvorí nové okno)

Prosper SC, Goudge CS, Lupo VR.

Zdroj‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Označenie‎: PubMed 17267882

Identifikátor digitálneho objektu‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (otvorí nové okno)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (otvorí nové okno)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Zdroj‎: Transfus Med 2012;22(5):344-9.

Označenie‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (otvorí nové okno)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (otvorí nové okno)

Bell SF, Rayment R, Collins PW, Collis RE.

Zdroj‎: Int J Obstet Anesth 2010;19(2):218-23.

Označenie‎: PubMed 20194010

Identifikátor digitálneho objektu‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (otvorí nové okno)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (otvorí nové okno)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Zdroj‎: Br J Anaesth 2012;108(6):984-9.

Označenie‎: PubMed 22490316

Identifikátor digitálneho objektu‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (otvorí nové okno)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (otvorí nové okno)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Zdroj‎: J Nippon Med Sch 2014;81(2):94-6.

Označenie‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (otvorí nové okno)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (otvorí nové okno)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Zdroj‎: Haemophilia 2012;18(1):25-33.

Označenie‎: PubMed 21624012

Identifikátor digitálneho objektu‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (otvorí nové okno)

Tisseel for management of traumatic postpartum haemorrhage. (otvorí nové okno)

Dhulkotia JS, Alazzam M, Galimberti A.

Zdroj‎: Arch Gynecol Obstet 2009;279(3):437-9.

Označenie‎: PubMed 18985368

Identifikátor digitálneho objektu‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (otvorí nové okno)

Uterine packing with chitosan-covered tamponade to treat postpartum hemorrhage. (otvorí nové okno)

Henrich W, Dückelmann A, Braun T, Hinkson L

Zdroj‎: Am J Obstet Gynecol 2024;230(3S):S1061-65.

Označenie‎: PubMed 38462249

Identifikátor digitálneho objektu‎: 10.1016/j.ajog.2022.11.1297

https://pubmed.ncbi.nlm.nih.gov/38462249/ (otvorí nové okno)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (otvorí nové okno)

Moriarty KT, Premila S, Bulmer PJ.

Zdroj‎: BJOG 2008;115(6):793-5.

Označenie‎: PubMed 18355369

Identifikátor digitálneho objektu‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (otvorí nové okno)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (otvorí nové okno)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Zdroj‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Označenie‎: PubMed 28219621

Identifikátor digitálneho objektu‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (otvorí nové okno)

Fibrin sealant for management of complicated obstetric lacerations. (otvorí nové okno)

Whiteside JL, Asif RB, Novello RJ.

Zdroj‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Označenie‎: PubMed 20093858

Identifikátor digitálneho objektu‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (otvorí nové okno)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (otvorí nové okno)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Zdroj‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Označenie‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (otvorí nové okno)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (otvorí nové okno)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Zdroj‎: Int J Obstet Anesth 2011;20(4):293-8.

Označenie‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (otvorí nové okno)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (otvorí nové okno)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Zdroj‎: Obstet Gynecol Surv 2012;67(7):426-35.

Označenie‎: PubMed 22926249

Identifikátor digitálneho objektu‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (otvorí nové okno)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (otvorí nové okno)

Karlsson O, Jeppsson A, Hellgren M.

Zdroj‎: Int J Obstet Anesth 2014;23(1):10-7.

Označenie‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (otvorí nové okno)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (otvorí nové okno)

Levy JH, Welsby I, Goodnough LT.

Zdroj‎: Transfusion 2014;54(5):1389-405.

Označenie‎: PubMed 24117955

Identifikátor digitálneho objektu‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (otvorí nové okno)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (otvorí nové okno)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Zdroj‎: Int J Obstet Anesth 2015;24(2):174-9.

Označenie‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (otvorí nové okno)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (otvorí nové okno)

Solomon C, Collis RE, Collins PW.

Zdroj‎: Br J Anaesth 2012;109(6):851-63.

Označenie‎: PubMed 23075633

Identifikátor digitálneho objektu‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (otvorí nové okno)